AZN vs OCUL · P/E 28, $288.38B cap vs rev $24.3M
AstraZeneca PLC (AZN) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the AZN and OCUL stock pages for the full models.
Not investment advice.